共 50 条
- [46] Mepolizumab. Anti-IL-5 monoclonal antibody therapy in patients with Severe Eosinophilic Asthma ALERGIA ASTMA IMMUNOLOGIA, 2018, 23 (03): : 137 - 142
- [47] Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (11): : 3026 - +